Factors affecting prostate cancer detection through asymptomatic prostate-specific antigen testing in primary care in England: evidence from the 2018 National Cancer Diagnosis Audit
British Journal of General Practice · 2025-05 · 75 (754) · e300-e305
DOI: 10.3399/bjgp.2024.0376 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of General Practice, online erschienen am 14.10.2024. Verfasst von Samuel Wd Merriel und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Primary Care and Health Services Research, University of Manchester, Manchester. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Prostate-Specific Antigen, Primary Health Care, Early Detection of Cancer. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Prostate-specific antigen (PSA) is used in primary care for prostate cancer detection, either for symptomatic assessment or asymptomatic testing following an informed decision.
Aim
To estimate the proportion of patients with prostate cancer who were diagnosed following asymptomatic PSA testing, and the patient and practice factors influencing this route. Design and setting The 2018 English National Cancer Diagnosis Audit (NCDA) data were analysed, with linkage to the National Cancer Registration and Analysis Service, practice-level Quality and Outcomes Framework (QOF), and GP Patient Survey (GPPS) data. All 2018 NCDA patients with a diagnosis of prostate cancer were included ( n = 9837).
Method
Patients with recorded biomarker testing and no recorded symptoms before diagnosis were classified as having asymptomatic PSA-detected prostate cancer. Patient (age, ethnicity, deprivation, and comorbidities) and practice (geographical location, area deprivation, list size, urgent suspected cancer referral rate, QOF outcomes, and GPPS results) factors were analysed for association with asymptomatic PSA testing using mixed-effects logistic regression models.
Results
In total, 1884 out of 9837 (19.2%) patients with prostate cancer were detected following asymptomatic PSA testing, 982 (52.1%) of whom were aged 50–69 years. Younger age, non-White ethnicity, lower deprivation, and lower comorbidity count were associated with an increased likelihood of diagnosis following asymptomatic PSA testing. There was a 13-fold variation between practices in the odds of detecting prostate cancer through asymptomatic PSA testing, without clear explanatory practice-level factors.
Conclusion
One in five patients with prostate cancer in England are diagnosed after asymptomatic PSA testing in primary care, with large variation in asymptomatic PSA detection between practices.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Primary Care and Health Services Research, University of Manchester, Manchester.
- Exeter collaboration of Academic Primary Care (APEx), University of Exeter, Exeter; Department of Health Data Science, University of Liverpool, Liverpool.
- University College London, London; data and research analyst, Cancer Research UK, London.
- Cancer Research UK, London; NHS England, London.
- National Cancer Registration and Analysis Service, NHS Digital, Leeds.
- Newcastle University, Newcastle upon Tyne.
ORCID-Profile: Samuel Wd Merriel, Nurunnahar Akter, Nadine Zakkak, Ruth Swann, Greg Rubin, Georgios Lyratzopoulos, Gary Abel
Zitieren
APA
Merriel, S. W., Akter, N., Zakkak, N., Swann, R., McPhail, S., Rubin, G., Lyratzopoulos, G., & Abel, G. (2025). Factors affecting prostate cancer detection through asymptomatic prostate-specific antigen testing in primary care in England: evidence from the 2018 National Cancer Diagnosis Audit. British Journal of General Practice, 75(754), e300-e305. https://doi.org/10.3399/bjgp.2024.0376
Vancouver
Merriel SW, Akter N, Zakkak N, Swann R, McPhail S, Rubin G, et al. Factors affecting prostate cancer detection through asymptomatic prostate-specific antigen testing in primary care in England: evidence from the 2018 National Cancer Diagnosis Audit. British Journal of General Practice. 2025;75(754):e300-e305. doi:10.3399/bjgp.2024.0376
BibTeX
@article{Merriel2025,
author = {Merriel, Samuel Wd and Akter, Nurunnahar and Zakkak, Nadine and Swann, Ruth and McPhail, Sean and Rubin, Greg and Lyratzopoulos, Georgios and Abel, Gary},
title = {Factors affecting prostate cancer detection through asymptomatic prostate-specific antigen testing in primary care in England: evidence from the 2018 National Cancer Diagnosis Audit},
journal = {British Journal of General Practice},
year = {2025},
volume = {75},
number = {754},
pages = {e300--e305},
doi = {10.3399/bjgp.2024.0376}
}
EUVIMED